FluoretiQ is a medical device company designing simple and effective bacterial detection systems for rapid diagnosis of infection.
FluoretiQ has raised $1.5M in total funding. The most recent round was Seed. The last funding was announced in February 2022.
FluoretiQ's investors include Creative Destruction Lab, SAIC, Deepbridge Capital, Oxford Investment Opportunity Network, MAINStream.
FluoretiQ is headquartered in Bristol, United Kingdom.
FluoretiQ is a medical device company designing simple and effective bacterial detection systems for rapid diagnosis of infection.
FluoretiQ is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"FluoretiQ — Funding & Investors." VCBacked, February 21, 2022, https://www.vcbacked.co/company/fluoretiq. Accessed September 30, 2026.
VCBacked. (2022). FluoretiQ — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/fluoretiq
{{cite web |title=FluoretiQ — Funding & Investors |url=https://www.vcbacked.co/company/fluoretiq |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated